Toshihiko Aranishi

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi et al. · Supportive Care in Cancer · 2009 · 197 citations

Oncology, Taxane Chemotherapy, Phase Iii +7

Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial

Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi et al. · Supportive Care in Cancer · 2012 · 100 citations

Medicine, Cancer Management, Adjuvant Chemotherapy +7

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)

Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi et al. · Supportive Care in Cancer · 2008 · 52 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +7

A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer

Katsumasa Kuroi, Kojiro Shimozuma, Yasuo Ohashi et al. · Japanese Journal of Clinical Oncology · 2008 · 39 citations · Full text

Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)

Yasushi Ishigaki, Alena Strizek, Toshihiko Aranishi et al. · Diabetes Therapy · 2020 · 21 citations · Full text